arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up

Minerva Neurosciences, Inc

NERV Health Care Biotechnology: Pharmaceutical Preparations
$2.30
▼ -3.8% Today
as of Oct 23, 16:50 ET
Last 30 days -42.64% Sep 14 → Oct 23
$2.16 $2.66 $3.16 $3.65 $4.15 Sep 14 Sep 22 Sep 30 Oct 07 Oct 15 Oct 23
Open
$2.37
High
$2.65
Low
$2.26
Volume
$137,586
Avg Vol
$186,903
Mkt Cap
$156M
P/E (TTM)
—
Beta
—
52w High
$8.80
52w Low
$2.24
Div Yield
—
Shares Out
$47M

Recent Press Releases & News last 60 days · 1 item

NERV earnings at a glance

Minerva Neurosciences, Inc (NERV) is scheduled to report earnings on Wednesday, November 4, 2026 — in 12 days. Analysts expect earnings per share of -$0.14, compared with -$0.36 in the same quarter last year (+61%). The options market is pricing a move of about ±138.7% after the report, a range of roughly -$0.89 to $5.49 from today's $2.30. Over its last 4 reports the stock rose the next day 0 times and fell 4, moving ±3.3% on average; after the most recent report on Aug 7, 2026 it moved -3.8%. That means options currently expect more movement than NERV has typically delivered. NERV beat the consensus EPS estimate in 2 of its last 5 reported quarters. Implied volatility is currently 33%. The share price of $2.30 sits near its 52-week low.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$2.24
$8.80
1% of range
Avg surprise (last 5)
-81.5%
Avg reaction (last 4)
-3.3%
0% positive
Latest IV / EM
3322%
EM ±138.7% · $3 · Sep 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-1.31$-0.24$0.83$1.90$2.97 Actual $-1.31Actual $-1.12Actual $-1.03Actual $-1.13Actual $-1.09Actual $2.97Actual $-0.50Est $-1.07Actual $-0.43Est $-0.95Actual $-0.36Est $-0.35Actual $-0.64Est $-0.11Actual $-0.17Est $-0.13Actual $-0.46 MarJunSepMarJunSepMar/2025Jun/2025Sep/20258KMar/20268K
Revenue vs Net Income Revenue Net income
$-125M$-88M$-51M$-14M$24M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Fri Aug 7, 20268K 2026-08-07 $-0.46 — — — -3.8% earnings
Tue May 5, 2026Mar/2026 $-0.17 $-0.13 -30.8% +66.0% -1.3% earnings
Wed Mar 11, 20268K 2026-03-11 $-0.64 $-0.11 -481.8% — -8.1% earnings
Wed Nov 5, 2025Sep/2025 $-0.36 $-0.35 -2.9% — — earnings
Thu Aug 14, 2025Jun/2025 $-0.43 $-0.95 +54.7% — — earnings
Tue May 13, 2025Mar/2025 $-0.50 $-1.07 +53.3% — -0.1% earnings
Mon Sep 30, 2024Sep 2024 $2.97 — — — — financials
Sun Jun 30, 2024Jun 2024 $-1.09 — — — — financials
Sun Mar 31, 2024Mar 2024 $-1.13 — — — — financials
Sat Sep 30, 2023Sep 2023 $-1.03 — — — — financials
Fri Jun 30, 2023Jun 2023 $-1.12 — — — — financials
Fri Mar 31, 2023Mar 2023 $-1.31 — — — — financials

Upcoming

DateFiscalTimeEPS EstLY EPSYoY %Δ
Wed Nov 4, 2026Sep/2026OTHER -$0.14-$0.36 +61.1%

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue————————
Cost of revenue————————
Gross profit————————
Operating income$-11M$-17M—$-3M$-3M$-4M—$-4M
Net income$17M$-125M—$-3M$-3M$-4M—$23M
EPS (diluted)$-0.14$-2.86—$-0.36$-0.43$-0.50—$2.97

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$25M$33M$82M$12M$15M$17M$21M$27M
Inventory————————
Total current assets$80M$79M$83M$13M$16M$18M$22M$28M
Total assets$95M$94M$98M$28M$30M$33M$37M$43M
Long-term debt————————
Total liabilities$297M$343M$234M$63M$63M$62M$63M$64M
Total equity$-213M$-254M$-141M$-35M$-32M$-29M$-26M$-22M

Implied volatility — last 90 days

44%864%1683%2502%3321% Jul 31 — IV 656% · EM ±125.6%Aug 07 — IV 764% · EM ±119.4%Aug 24 — IV 105% · EM ±21.8%Aug 25 — IV 59% · EM ±12.0%Aug 27 — IV 45% · EM ±8.8%Aug 28 — IV 97% · EM ±18.6%Aug 31 — IV 124% · EM ±21.9%Sep 01 — IV 162% · EM ±27.9%Sep 02 — IV 167% · EM ±27.9%Sep 03 — IV 119% · EM ±19.2%Sep 04 — IV 189% · EM ±29.5%Sep 07 — IV 212% · EM ±29.3%Sep 08 — IV 243% · EM ±32.0%Sep 09 — IV 349% · EM ±43.7%Sep 10 — IV 356% · EM ±42.1%Sep 11 — IV 382% · EM ±42.2%Sep 14 — IV 612% · EM ±51.1%Sep 15 — IV 884% · EM ±64.0%Sep 17 — IV 3322% · EM ±138.7%

Sector peers

NERV earnings FAQ

When is NERV's next earnings date?

Minerva Neurosciences, Inc is expected to report on November 4, 2026.

What is NERV's expected move for earnings?

Options currently price a move of about ±138.7%, or $3.19 per share either way from $2.30.

How does NERV stock usually react to earnings?

Across the last 4 reports the average next-day move was ±3.3%, up 0 times and down 4 times.

What EPS are analysts expecting from Minerva Neurosciences, Inc?

The consensus estimate is -$0.14 per share, versus -$0.36 a year ago.

What is NERV's implied volatility?

NERV's at-the-money implied volatility is about 33% based on the latest options snapshot.

🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.